Cordia oncocalyx
Cordia oncocalyx · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Cordia oncocalyx is a distinctive botanical species known for its unique chemical profile and medicinal potential. Within its complex organic makeup, researchers have identified the significant secondary metabolite known as Oncocalyxone A. This specific compound serves as a primary interest for scientists studying the plant's bioactive properties. Understanding the role of such chemicals is essential for uncovering the therapeutic possibilities held within the species. Consequently, this plant remains a subject of profound importance in the field of phytochemical exploration.
- Synonyms
- Auxemma Gardneriana · Auxemma Oncocalyx
- Common names
- Not available
- Family
- Boraginaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Cordia oncocalyx is a versatile species known by a wide array of regional monikers. In various locales, it is frequently referred to as Louro-branco or simply Pau-branco. It also carries the distinct name Pau-Branco-do-Sertão, reflecting its specific environmental connections. Some communities may call it Palo blanco, depending on the linguistic influence of the area. Finally, the plant is sometimes identified as Pau-branco-preto, showcasing the rich diversity of its common names.
Sources: Catalogue of Life (COL)
Synonyms
Cordia oncocalyx is a botanical subject that is frequently identified through various taxonomic labels. In many scientific records, this plant is recognized by the synonym Auxemma gardneriana. It is also commonly referred to in literature as Auxemma oncocalyx. These overlapping names highlight the complex shifting nature of botanical classification over time. Understanding these relationships is essential for researchers seeking to maintain accuracy in plant identification.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Cordia oncocalyx is a distinctive botanical specimen that belongs to the kingdom Plantae. Within this vast kingdom, the plant is classified under the class Equisetopsida. It further falls into the order Boraginales, showcasing its specific evolutionary lineage. This species is a member of the Boraginaceae family, which defines its structural characteristics. Ultimately, its scientific identity is anchored within the genus Cordia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Boraginales |
| Family | Boraginaceae |
| Genus | Cordia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Cordia oncocalyx is a distinctive plant species primarily found throughout the diverse landscapes of Southern America. Its presence is particularly notable within the lush ecosystems of Brazil, where it thrives in various habitats. Within the country, the species shows a concentrated distribution in the Northeast region, highlighting its ecological importance there. Understanding its geographic range provides valuable insight into the specific environmental conditions it requires to flourish. As a native component of these tropical zones, it plays a unique role in the local biodiversity.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Cordia oncocalyx is a self-supporting plant that takes the form of a sturdy tree. This species typically reaches a maximum height of 7.5 meters, though it can occasionally grow up to 12 meters. Its structural integrity allows it to stand firmly as a prominent feature in its natural habitat. Whether small or large, the tree maintains a consistent growth habit throughout its life cycle.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Cordia oncocalyx contains a notable active compound known as Oncocalyxone A. Recent research has focused on evaluating this substance to determine its potential for therapeutic use without causing genetic damage. While studies show that Oncocalyxone A can exhibit cytotoxicity during specific cell cycle phases, it did not demonstrate any genotoxic effects in the tested lymphocyte cultures. This lack of genotoxicity is a significant finding, as it suggests the compound may avoid the risks of DNA damage often associated with traditional chemotherapy. Consequently, these results provide a promising foundation for further investigation into the molecular mechanisms and safety of this agent.
Conditions
Cordia oncocalyx, through its active compounds oncocalyxones A and C, demonstrates significant cytotoxicity against various tumor cells in vitro. These compounds specifically exhibit antiproliferative effects against the CEM leukaemia cell line and the SW1573 lung tumour line. Research also indicates that these substances are capable of treating CCD922 normal skin fibroblasts by inhibiting cell growth and DNA synthesis. Furthermore, the medicinal potential of these derivatives extends to the treatment of acute leukemia. Ultimately, these findings highlight the plant's ability to act against diverse cancer cell lines, including multidrug-resistant varieties.